CHEMMEDCHEM (INTERNET)
-
- Visão geral
-
- Metrics
-
- Identidade
-
- Ver todos
-
Visão geral
Qualis
código do país
tipo
publicação venue de
-
Fragment merging strategies with known pyrimidine scaffolds targeting dihydrofolate reductase from Mycobacterium tuberculosis.
18:e202300240.
2023-01-01
-
Investigating the Lack of Translation from Cruzain Inhibition to Activity with Machine Learning and Chemical Space Analyses.
18:e202200434.
2023-01-01
-
Synthesis and Anti¿Mycobacterium tuberculosis Activity of Imidazo[2,1¿b][1,3]oxazine Derivatives Against Multidrug¿Resistant Strains.
1:1-13.
2023-01-01
-
Biochemical Screening of Potent Zika Virus Protease Inhibitors.
17:Epub 2022 Feb9.
2022-01-01
-
Jumping From Fragment To Drug Via Smart Scaffolds.
17:e202200092.
2022-01-01
-
Natural Products from Annonaceae as Potential Antichagasic Agents.
00:1-10.
2022-01-01
-
Recent Advances in the Prediction of Pharmacokinetics Properties in Drug Design Studies: A Review.
17:1-13.
2022-01-01
-
Synthesis and Vasorelaxant Activity of Nitrate−Coumarin Derivatives.
17:e202200476.
2022-01-01
-
Synthesis, Design, and Structure-Activity Relationship of a Benzenesulfonylpiperazine Series against Trypanosoma cruzi.
.:..
2022-01-01
-
When Two Become One: Conformational Changes in FXR/RXR Heterodimers Bound to Steroidal Antagonists.
1:1.
2022-01-01
-
6-Methyl-7-Aryl-7-Deazapurine Nucleosides as Anti- Trypanosoma cruzi Agents: Structure-Activity Relationship and in-vivo Efficacy.
16:1-2253.
2021-01-01
-
A -Golden Age- for the discovery of new antileishmanial agents: Current status of leishmanicidal gold complexes and prospective targets beyond the trypanothione system.
16:1682-1696.
2021-01-01
-
Discovery of Benzofuroxan Derivatives as Potent Agents Active Against Multidrug¿Resistant Mycobacterium tuberculosis.
1:1-1282.
2021-01-01
-
Discovery of a novel inhibitor of human purine nucleoside phosphorylase by a simple hydrophilic interaction liquid chromatography (HILIC-UV) enzymatic assay.
1:1-1334.
2021-01-01
-
Do Drug¿likeness Rules Apply for Oral Prodrugs?.
16:1446-1456.
2021-01-01
-
Ligand Accessibility Insights to the Dengue Virus NS3-NS2B Protease Assessed by Long-Timescale Molecular Dynamics Simulations.
16:0246-12.
2021-01-01
-
Multitarget Inhibition of Histone Deacetylase (HDAC) and Phosphatidylinositol-3-kinase (PI3K): Current and Future Prospects.
16:448-457.
2021-01-01
-
Natural and Semisynthetic Pentacyclic Triterpenes for Chronic Myeloid Leukemia Therapy: Reality, Challenges and Perspectives.
16:1835-1860.
2021-01-01
-
Synthesis and evaluation of antioxidant, anti¿edematogenic and antinociceptive properties of new selenium¿sulfa compounds.
17:e202100507.
2021-01-01
-
Tetrahydroquinoline/4,5¿dihydroisoxazole molecular hybrids as novel inhibitors of Breast Cancer Resistance Protein (BCRP/ABCG2).
16:1-10.
2021-01-01
-
Turning Donepezil into a Multi-Target-Directed Ligand through a Merging Strategy.
16:187-198.
2021-01-01
-
A novel hybrid of chloroquine and primaquine linked by gold(I): Multi-target and multi-phase antiplasmodial agent.
1:1-1.
2020-01-01
-
Antitumour anthracyclines: progress and perspectives.
15:1-17.
2020-01-01
-
Artificial intelligence applied for the rapid identification of new antimalarial candidates with dual-stage activity.
1:1-1103.
2020-01-01
-
Comparing the Antileishmanial Activity of Gold(I) and Gold(III) Compounds in L. amazonensis and L. braziliensis in Vitro.
15:01-08.
2020-01-01
-
Design, Synthesis, and Pharmacological Evaluation of First-in-Class Multitarget N -Acylhydrazone Derivatives as Selective HDAC6/8 and PI3Kα Inhibitors.
15:1-16.
2020-01-01
-
Development of the First Potential Nonpeptidic Positron Emission Tomography Tracer for the Imaging of CCR2 Receptors.
15:cmdc.202000728-1.
2020-01-01
-
Discovery of Alternative Chemotherapy Options for Leishmaniasis via Computational Studies of Asteraceae.
1:1234-1245.
2020-01-01
-
Dual Parasiticidal Activities of Phthalimides: Synthesis and Biological Profile against Trypanosoma cruzi and Plasmodium falciparum.
01:01-12.
2020-01-01
-
Pharmacokinetic parameters of HIV¿1 Protease Inhibitors.
1:1-10.
2020-01-01
-
S -(4-Methoxyphenyl)-4-methoxybenzenesulfonothioate as a Promising Lead Compound for the Development of a Renal Carcinoma Agent.
15:1-11.
2020-01-01
-
Sulfonylguanidine Derivatives as Potential Antimelanoma Agents.
15:1113-1117.
2020-01-01
-
Sulfurated and oxygenated imidazoline derivatives: synthesis, antioxidant activity and light mediated antibacterial activity.
15:1-12.
2020-01-01
-
Synthesis and Structure−Activity Relationships of Imidazopyridine/Pyrimidine- and Furopyridine-Based Anti-infective Agents against Trypanosomiases.
15:1-11.
2020-01-01
-
Synthesis and antitrypanosomal activity of novel 1,4-dissubstituted-triazole compounds based on 2-nitroimidazole scaffold: a structure-activity relationship (SAR) study.
-:--2028.
2020-01-01
-
Synthesis and evaluation of new 2-aminothiophene derivatives as Staphylococcus aureus efflux pump inhibitors.
1:1-12.
2020-01-01
-
Synthesis of 2-Organylchalcogenopheno[2,3- b ]pyridines from Elemental Chalcogen and NaBH 4 /PEG-400 as a Reducing System: Antioxidant and Antinociceptive Properties.
1:1-1751.
2020-01-01
-
Synthesis, molecular docking and preliminary evaluation of 2¿(1,2,3¿triazoyl)¿benzaldehydes as multifunctional agents for the treatment of Alzheimer's disease..
1:1-10.
2020-01-01
-
The Effects of the Alkaloid Tambjamine J on Mice Implanted with Sarcoma 180 Tumor Cells.
16:1-23.
2020-01-01
tem uma área de assunto
publisher
is open access
-
False
invalid format
is in DOAJ
-
False
invalid format
Metrics
2 year mean citedness
H index
i10 index
Identidade
ISSN-L
openalex identifier
-
https://openalex.org/S136164820
International Standard Serial Number (ISSN)